Total planned funding: $679,281,722
Clear active filters
University
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Kenya | $123,368,312 |
Mozambique | $119,371,126 |
Tanzania | $79,421,651 |
South Africa | $59,023,942 |
Nigeria | $40,181,108 |
Ethiopia | $34,257,937 |
Uganda | $31,327,937 |
Zambia | $31,300,621 |
Botswana | $20,205,323 |
Eswatini | $19,563,797 |
Malawi | $19,095,000 |
Democratic Republic of the Congo | $17,323,829 |
Haiti | $17,213,404 |
Rwanda | $11,687,927 |
Côte d'Ivoire | $8,502,979 |
Angola | $6,546,736 |
South Sudan | $4,936,807 |
Caribbean Region | $4,738,000 |
Vietnam | $4,621,323 |
Lesotho | $4,566,513 |
Namibia | $4,475,794 |
Central Asia Region | $4,324,835 |
Central America Region | $2,971,937 |
Zimbabwe | $1,975,000 |
Cameroon | $1,579,884 |
Burma | $1,500,000 |
Ghana | $1,220,000 |
Ukraine | $1,200,000 |
Burundi | $1,100,000 |
India | $1,100,000 |
Dominican Republic | $450,000 |
Guyana | $130,000 |
Russia | $0 |
China | $0 |
Organizational Types
University | $679,281,722 |
Program Areas
Treatment | $264,434,524 |
Prevention | $142,971,890 |
Care | $119,799,942 |
Governance and Systems | $115,075,728 |
Testing | $36,718,024 |
Budget Codes
HTXS: Treatment: Adult Treatment | $226,137,027 |
HVSI: Strategic Information | $58,934,463 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $56,176,679 |
HBHC: Care: Adult Care and Support | $55,508,105 |
OHSS: Health Systems Strengthening | $38,154,737 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $37,593,619 |
HVCT: Testing: HIV Testing and Counseling | $36,718,024 |
PDTX: Treatment: Pediatric Treatment | $34,520,211 |
HVTB: Care: TB/HIV | $34,267,614 |
HVOP: Sexual Prevention: Other Sexual Prevention | $30,152,407 |
HLAB: Laboratory Infrastructure | $17,986,528 |
PDCS: Care: Pediatric Care and Support | $15,067,220 |
HKID: Care: Orphans and Vulnerable Children | $14,957,003 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $12,391,147 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,764,118 |
HTXD: Treatment: ARV Drugs | $3,777,286 |
HMIN: Biomedical Prevention: Injection Safety | $972,298 |
HMBL: Biomedical Prevention: Blood Safety | $921,622 |